Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
9138studies shown
Showing 5,053-5,064 of 9,138
Drug study icon
TerminatedNCT03768726

Safety study of flexible Doses Of Oral Ziprasidone in Bipolarity

This study has public registry information in the United States. It is testing flexible Doses Of Oral Ziprasidone for Bipolarity.

Multiple locations, including Orange City
BipolarityOtherFrom 10 Years to 17 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
Other study type icon
TerminatedNCT03121586

Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

This study has public registry information. It focuses on schizophrenia and currently lists study information in Argentina, Bulgaria, Canada, Croatia, Czech Republic, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Ukraine, and the United States.

Multiple locations, including Phoenix
SchizophreniaOtherOver 18 Years
Countries
United States, Canada, Argentina, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Behavioral study icon
TerminatedNCT01121536

Safety and Efficacy of Armodafinil Treatment for depression

This study has public registry information in the United States, in Australia, in France, .... It is testing safety and Efficacy of Armodafinil Treatment for depression.

Multiple locations, including Birmingham
Bipolarity, DepressionOtherFrom 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Cephalon
Condition
Bipolarity, Depression